ARTICLE | Company News
Warnex deal
May 21, 2012 7:00 AM UTC
In its 1Q12 earnings, Warnex said it sold its Analytical Services division to its NeoPharm Labs Inc. division for cash proceeds of C$300,000 ($299,100). The Analytical Services division provides quality control services, including chemistry, chromatography, microbiology, method development and validation, and stability studies. Warnex provides laboratory services to the pharmaceutical sector, including bioequivalence and bioavailability studies. ...